Current treatment and research efforts include:
Male and Female Sexual Dysfunction (primary and secondary)
- Management of male and female sexual dysfunction in premature gonadal/ovarian failure patients
- Clinical research in male sexual dysfunction in patients with cancer and diabetes
Neuroendocrine Tumors (carcinoids, pancreatic endocrine tumors, etc.)
- These tumors present a significant challenge both at diagnosis and in treatment. Research efforts include:
- Advancing the management of neuroendocrine tumors with the use of radioactive iodine MIBG
- Investigation of endocrine complications as a result of chemotherapy, radiation therapy and bone marrow transplant in cancer patients.
- Management of immunosuppressive therapy-related endocrine complications.
- Development of clinical practice guidelines for the management of hypothalamic-pituitary endocrine complications after bone marrow transplant.
- Aggressive prevention and treatment of bone marrow transplant osteoporosis in both men and women.
- After thyroid cancer surgery, standard treatment consists of radioiodine to ablate residual tumor cells. However, we have been exploring methods of augmenting or supplanting this therapy. Initiatives include:
- Continued clinical research in thyroid cancer exploring new diagnostic and therapeutic alternatives to radioactive iodine therapy
- Providing compassionate use of recombinant human thyroid stimulating hormone (Thyrogen) for thyroid cancer therapy